Epigenetic aspects of genotoxic and non‐genotoxic hepatocarcinogenesis: Studies in rodents
Open Access
- 18 September 2007
- journal article
- review article
- Published by Wiley in Environmental and Molecular Mutagenesis
- Vol. 49 (1) , 9-15
Abstract
Hepatocellular carcinoma, which is one of the most prevalent life‐threatening human cancers, is showing an increased incidence worldwide. Recent evidence indicates that the development of hepatocellular carcinoma is associated with not only genetic alterations, but also with profound epigenetic changes. This review summarizes the current knowledge about epigenetic alterations during rodent hepatocarcinogenesis, considers the similarities and differences in epigenetic effects of genotoxic and non‐genotoxic rodent liver carcinogens, and discusses the possible role of these effects in the causality of liver tumor development. Environ. Mol. Mutagen., 2008. Published 2007 Wiley‐Liss, Inc.Keywords
This publication has 64 references indexed in Scilit:
- Epigenetic effects of the continuous exposure to peroxisome proliferator WY-14,643 in mouse liver are dependent upon peroxisome proliferator activated receptor αMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2007
- The Epigenomics of CancerCell, 2007
- The epigenetic magic of histone lysine methylationThe FEBS Journal, 2006
- LINE‐1 Hypomethylation in a Choline‐Deficiency‐Induced Liver Cancer in Rats: Dependence on Feeding PeriodBioMed Research International, 2006
- Temporal Correlation of Pathology and DNA Damage With Gene Expression in a Choline-Deficient Model of Rat Liver Injury *Hepatology, 2005
- Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancerNature Genetics, 2005
- Methylation of Histone H4 Lysine 20 Controls Recruitment of Crb2 to Sites of DNA DamageCell, 2004
- Disregulation of E-cadherin in transgenic mouse models of liver cancerLaboratory Investigation, 2004
- The history of cancer epigeneticsNature Reviews Cancer, 2004
- The Hallmarks of CancerCell, 2000